Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols | Madrid | Healthcare | Pharmaceuticals | €6.94B | 44.6x | 0.01 | €10.24 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €6.94B | 44.6x | 0.01 | €8.33 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.6% Upside | Upgrade to Pro+ | |
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €3.80B | 26.7x | -1.46 | €73.70 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.2% Upside | Upgrade to Pro+ | |
Almirall | Madrid | Healthcare | Pharmaceuticals | €1.84B | -48.3x | 0.2 | €8.61 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.8% Upside | Upgrade to Pro+ | |
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.16B | 11.9x | 1.58 | €3.70 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.7% Upside | Upgrade to Pro+ | |
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €745.05M | -425x | 3.73 | €42.48 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.4% Upside | Upgrade to Pro+ | |
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €217.76M | 23x | -11.04 | €2.72 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.6% Upside | Upgrade to Pro+ | |
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €21.89M | -3.9x | €3 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.6% Downside | Upgrade to Pro+ |